Search

everythinglearnresearchcommunity

for

Search:↓

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Bimekizumab quickly improves psoriasis symptoms and skin at the molecular level.

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Dupilumab effectively controls symptoms in infants with Netherton syndrome.

PPX causes much less hair loss than traditional taxanes.

PRAME helps distinguish between benign and malignant skin cells in most cases.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

The PS-b-PAA copolymer nanomicelles are effective for delivering a cancer treatment drug in photodynamic therapy.

3D imaging effectively tracks skin changes in vitiligo treatment.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Secukinumab and acitretin together may quickly and effectively treat severe generalized pustular psoriasis.

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.

Dupilumab may help regrow hair in people with severe alopecia.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Trastuzumab may cause tufted hair folliculitis as a side effect.

A medication for skin rash also unexpectedly treated hair loss in a patient.

The drug combination was safe and showed promise in treating advanced tumors.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

A new microneedle patch significantly improves melanoma treatment by using a special material to activate cancer-fighting drugs and disrupt cancer cells.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.